On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
Dr. Wolkers did her PhD in Ton Schumacher’s lab. After her postdoctoral training with Stephen Schoenberger (La Jolla Institute), Douglas Green (St. Jude’s Memphis), and Jan-Paul Medema (AmsterdamUMC-AMC), Dr. Wolkers started her group in 2010 at Sanquin Research, Amsterdam. Since then, she is fascinated by the molecular mechanisms that dictate CD8 T-cell effector function. Her group showed for instance that post-transcriptional mechanisms define the production of pro-inflammatory cytokines and define their capacity to kill tumors and infected cells. Furthermore, her group uncovered surface markers that can distinguish cytotoxic from non-cytotoxic T cells, a tool that may be important for the development of effective T-cell therapies. Monika holds an ERC consolidator grant and is an Oncode Investigator.
